We previously reported that gene therapy by combination of VEGF165 and hepatocyte growth factor (HGF) [8] resulted in enhanced effect in a mouse model of limb ischemia and addressed potent mitogenic and pro-survival effects of VEGF165+HGF in endothelium as a putative mechanism of increased blood vessel formation [8]. This evidence concerns the gene HGF and limb ischemia.